دورية أكاديمية
P2X 7 Receptor and Extracellular Vesicle Release.
| العنوان: | P2X |
|---|---|
| المؤلفون: | Golia MT; National Research Council of Italy, Institute of Neuroscience, Via Raoul Follereau 3, 20854 Vedano al Lambro, Italy., Gabrielli M; National Research Council of Italy, Institute of Neuroscience, Via Raoul Follereau 3, 20854 Vedano al Lambro, Italy., Verderio C; National Research Council of Italy, Institute of Neuroscience, Via Raoul Follereau 3, 20854 Vedano al Lambro, Italy. |
| المصدر: | International journal of molecular sciences [Int J Mol Sci] 2023 Jun 06; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 06. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, [2000- |
| مواضيع طبية MeSH: | Brain* , Extracellular Vesicles*, Receptors, Purinergic P2X7 ; Adenosine Triphosphate |
| مستخلص: | Extensive evidence indicates that the activation of the P2X |
| References: | Mol Biol Rep. 2021 Mar;48(3):2133-2142. (PMID: 33650080) J Neurochem. 2006 Nov;99(3):745-58. (PMID: 16836656) Biochem Pharmacol. 2021 May;187:114385. (PMID: 33359010) Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40. (PMID: 12220547) Immunol Today. 1990 Aug;11(8):274-7. (PMID: 2206271) EMBO J. 2006 Nov 1;25(21):5071-82. (PMID: 17036048) Prog Neurobiol. 2006 Apr;78(6):327-46. (PMID: 16697102) Ann Neurol. 2012 Oct;72(4):610-24. (PMID: 23109155) Biochem Pharmacol. 2022 Sep;203:115192. (PMID: 35905971) Front Immunol. 2020 Jun 10;11:1179. (PMID: 32587592) FASEB J. 2008 Mar;22(3):861-9. (PMID: 17928361) J Immunol. 2009 Mar 1;182(5):2898-908. (PMID: 19234185) J Mol Endocrinol. 2015 Apr;54(2):R75-88. (PMID: 25591582) Front Cell Neurosci. 2019 Nov 08;13:476. (PMID: 31787881) Expert Opin Ther Targets. 2019 Mar;23(3):165-176. (PMID: 30691318) Cells. 2022 Dec 23;12(1):. (PMID: 36611856) J Cell Biol. 2016 Jun 20;213(6):617-29. (PMID: 27325789) J Cell Biol. 1999 Nov 29;147(5):1023-38. (PMID: 10579722) J Immunol. 2004 Jul 15;173(2):1202-8. (PMID: 15240711) Blood. 2007 May 1;109(9):3856-64. (PMID: 17192399) Nat Neurosci. 2015 Nov;18(11):1584-93. (PMID: 26436904) Sci Rep. 2019 Jul 1;9(1):9477. (PMID: 31263146) Biochim Biophys Acta. 2009 May;1788(5):1176-87. (PMID: 19306841) Purinergic Signal. 2021 Sep;17(3):331-344. (PMID: 33987781) J Leukoc Biol. 2004 Jun;75(6):1173-82. (PMID: 15075366) J Immunol. 2006 Apr 1;176(7):3877-83. (PMID: 16547218) Recent Pat Anticancer Drug Discov. 2019;14(1):32-38. (PMID: 30652649) Eur J Biochem. 2001 Nov;268(21):5601-8. (PMID: 11683883) Semin Immunopathol. 2018 Sep;40(5):477-490. (PMID: 29594331) iScience. 2021 Nov 26;24(12):103520. (PMID: 34950860) Trends Pharmacol Sci. 2007 Sep;28(9):465-72. (PMID: 17692395) Biochem Biophys Res Commun. 2017 Feb 19;483(4):1178-1186. (PMID: 27659705) J Immunol. 1999 Aug 15;163(4):1958-65. (PMID: 10438932) Cell Signal. 2007 Apr;19(4):855-66. (PMID: 17175137) Sci Signal. 2019 Jan 08;12(563):. (PMID: 30622196) J Neurochem. 2012 Sep;122(6):1118-28. (PMID: 22774935) Cell Death Differ. 2014 Apr;21(4):582-93. (PMID: 24336048) Purinergic Signal. 2017 Dec;13(4):529-544. (PMID: 28823092) Immunol Lett. 2015 Oct;167(2):116-24. (PMID: 26277554) FASEB J. 2019 May;33(5):6442-6455. (PMID: 30776316) Front Pharmacol. 2017 Dec 13;8:910. (PMID: 29321741) Immunity. 2003 Oct;19(4):571-82. (PMID: 14563321) Biophys J. 2013 Jun 18;104(12):2612-21. (PMID: 23790369) Front Cell Neurosci. 2022 Sep 13;16:984690. (PMID: 36176630) Purinergic Signal. 2021 Mar;17(1):55-61. (PMID: 33011962) Curr Med Chem. 2017;24(21):2261-2275. (PMID: 28266268) Front Immunol. 2015 May 19;6:204. (PMID: 26042119) Science. 1999 Aug 6;285(5429):895-8. (PMID: 10436159) Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228. (PMID: 29339798) Physiol Rev. 2002 Oct;82(4):1013-67. (PMID: 12270951) Brain. 2020 May 1;143(5):1476-1497. (PMID: 32355963) J Immunol. 2009 Apr 15;182(8):5052-62. (PMID: 19342685) J Extracell Vesicles. 2021 Jul;10(9):e12114. (PMID: 34276899) J Immunol. 2007 Aug 1;179(3):1913-25. (PMID: 17641058) Front Mol Neurosci. 2020 Jun 03;13:94. (PMID: 32581707) Elife. 2020 Nov 02;9:. (PMID: 33135636) Nature. 1979 Jun 7;279(5713):541-2. (PMID: 450099) J Immunol. 2003 Jun 1;170(11):5728-38. (PMID: 12759456) J Immunol. 2005 Jun 1;174(11):7268-77. (PMID: 15905573) Cell Death Dis. 2019 Feb 20;10(3):174. (PMID: 30787269) ACS Chem Neurosci. 2018 Jun 20;9(6):1416-1425. (PMID: 29543435) Prog Neurobiol. 2022 Jan;208:102173. (PMID: 34516970) EMBO J. 2009 Apr 22;28(8):1043-54. (PMID: 19300439) J Extracell Vesicles. 2015 May 14;4:27066. (PMID: 25979354) Neuropharmacology. 2014 Jun;81:142-52. (PMID: 24508709) J Biol Chem. 1987 Jun 25;262(18):8884-8. (PMID: 3597398) Purinergic Signal. 2009 Jun;5(2):163-73. (PMID: 19189228) Eur J Immunol. 2012 Dec;42(12):3334-45. (PMID: 22996386) FASEB J. 2007 Jun;21(8):1926-33. (PMID: 17314141) J Extracell Vesicles. 2018 Nov 23;7(1):1535750. (PMID: 30637094) Mol Cell. 2002 Aug;10(2):417-26. (PMID: 12191486) Mol Neurodegener. 2020 Aug 18;15(1):47. (PMID: 32811520) Front Immunol. 2017 Jul 24;8:862. (PMID: 28791020) Acta Neuropathol Commun. 2019 Nov 19;7(1):184. (PMID: 31744532) Infect Immun. 2010 Dec;78(12):5116-25. (PMID: 20837713) J Immunol. 2007 Jul 1;179(1):186-94. (PMID: 17579037) Cell Rep. 2022 May 10;39(6):110791. (PMID: 35545052) Prog Neurobiol. 2021 Nov;206:102139. (PMID: 34391810) J Cell Biol. 2020 Oct 5;219(10):. (PMID: 32970791) Mol Psychiatry. 2019 Jan;24(1):108-125. (PMID: 29934546) J Immunol. 2010 Sep 15;185(6):3740-9. (PMID: 20709956) Am J Physiol Cell Physiol. 2009 Aug;297(2):C430-9. (PMID: 19494237) Atherosclerosis. 2002 May;162(1):55-61. (PMID: 11947897) J Physiol. 1999 Sep 15;519 Pt 3:723-36. (PMID: 10457086) Cell Transplant. 2017 Apr 13;26(4):669-677. (PMID: 28403913) Mol Biol Cell. 2003 Jul;14(7):2655-64. (PMID: 12857854) Int J Mol Sci. 2020 Aug 20;21(17):. (PMID: 32825423) Brain. 2022 Aug 27;145(8):2849-2868. (PMID: 35254410) Diabetologia. 2000 Oct;43(10):1248-56. (PMID: 11079743) Front Mol Neurosci. 2021 Feb 09;14:641570. (PMID: 33642994) J Neurosci. 2009 Mar 25;29(12):3781-91. (PMID: 19321774) Immunity. 2001 Nov;15(5):825-35. (PMID: 11728343) |
| معلومات مُعتمدة: | RF-2018-12365333 Ministry of Health |
| فهرسة مساهمة: | Keywords: P2X7 receptor; extracellular vesicles; inflammation; neurodegeneration |
| المشرفين على المادة: | 0 (Receptors, Purinergic P2X7) 8L70Q75FXE (Adenosine Triphosphate) |
| تواريخ الأحداث: | Date Created: 20230628 Date Completed: 20230629 Latest Revision: 20230701 |
| رمز التحديث: | 20230701 |
| مُعرف محوري في PubMed: | PMC10298639 |
| DOI: | 10.3390/ijms24129805 |
| PMID: | 37372953 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms24129805 |